Is CD26 (Dipeptidyl Peptidase IV) a Novel Candidate For Controlling NASH Pathogenesis?


ŞİMŞEK H. , TATAR G., BALABAN H. Y.

12th United European Gastroenterology Week (UEGW), prag, 01 January 2004

  • Publication Type: Conference Paper
  • City: prag